We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

31 hedge funds and large institutions have $17.5M invested in VolitionRx Ltd in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

84% more capital invested

Capital invested by funds: $9.51M → $17.5M (+$7.96M)

24% more funds holding

Funds holding: 25 → 31 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.01% less ownership

Funds ownership: 0.38% → 0.38% (-0.01%)

Holders
31
Holders Change
+6
Holders Change %
+24%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
10
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$358K
2
Morgan Stanley
Morgan Stanley
New York
+$209K
3
Renaissance Technologies
Renaissance Technologies
New York
+$200K
4
JP Morgan Chase
JP Morgan Chase
New York
+$165K
5
VF
Virtu Financial
New York
+$80.1K

Top Sellers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
-$501K
2
CS
Credit Suisse
Switzerland
-$116K
3
OC
Oppenheimer & Co
New York
-$107K
4
LCM
Leisure Capital Management
California
-$42K
5
Bessemer Group
Bessemer Group
New Jersey
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$10.2M -$501K -6,296 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.8M +$9.08K +114 +0.7%
BCM
3
Bridgeway Capital Management
Texas
$1.26M – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.22M +$358K +4,497 +71%
Morgan Stanley
5
Morgan Stanley
New York
$825K +$209K +2,625 +56%
Renaissance Technologies
6
Renaissance Technologies
New York
$378K +$200K +2,515 +298%
JP Morgan Chase
7
JP Morgan Chase
New York
$233K +$165K +2,070 New
Northern Trust
8
Northern Trust
Illinois
$215K +$955 +12 +0.6%
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$205K +$15.9K +200 +12%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$157K – – –
VF
11
Virtu Financial
New York
$113K +$80.1K +1,006 New
ARTA
12
A.R.T. Advisors
New York
$91K +$64.2K +807 New
Charles Schwab
13
Charles Schwab
California
$87K – – –
GBA
14
Garrison Bradford & Associates
New York
$87K – – –
Creative Planning
15
Creative Planning
Kansas
$85K – – –
AG
16
Advisor Group
Arizona
$83K +$19.9K +250 +51%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$79K – – –
OC
18
Oppenheimer & Co
New York
$72K -$107K -1,344 -68%
HFM
19
Hartford Financial Management
Connecticut
$47K – – –
BlackRock
20
BlackRock
New York
$42K +$1.67K +21 +6%
Bank of America
21
Bank of America
North Carolina
$39K +$3.19K +40 +13%
RE
22
RBC Europe
United Kingdom
$37K – – –
UBS Group
23
UBS Group
Switzerland
$25K +$8.04K +101 +81%
Credit Agricole
24
Credit Agricole
France
$22K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$20K +$14.2K +178 New
1
2

VNRX Hedge Fund Activity: Q3 2019 in Review

31 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2019, worth a combined $17.5M — up 84% from $9.51M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VNRX positions and 3 closed out — a net gain of 6 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $358K. The largest seller was Lagoda Investment Management, cutting an estimated $501K.

  • 31 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2019, up from 25 in Q2 2019.
  • Funds reported $17.5M of VolitionRx Ltd stock for Q3 2019, up 84% quarter-over-quarter.
  • 9 funds opened new VolitionRx Ltd positions in Q3 2019 and 3 closed out, a net change of +6 holders.
  • The largest VolitionRx Ltd buyer in Q3 2019 was Geode Capital Management, an estimated $358K added.
  • The largest VolitionRx Ltd seller in Q3 2019 was Lagoda Investment Management, an estimated $501K sold.

Based on aggregated 13F filings for Q3 2019.